$ONCY Headlines Oncolytics prices offering at 14
Post# of 5326
Posted On: 01/23/2014 10:15:52 PM
$ONCY Headlines
Oncolytics prices offering at 14% discount 2:21 p.m. Feb. 20, 2013 - MarketWatch.com
Canada hot stocks : Oncolytics, Just Energy 12:37 p.m. Feb. 8, 2013 - MarketWatch.com
Oncolytics shares up on positive Reolysin results 8:59 a.m. Feb. 8, 2013 - MarketWatch.com
Oncolytics rises 27% after positive Phase III data 8:45 a.m. Dec. 13, 2012 - Steve Gelsi
Oncolytics Biotech up 27% in premarket 8:38 a.m. Dec. 13, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 3:18 p.m. Sept. 12, 2012 - MarketWatch
Tuesday's biggest stock gainers and decliners 4:24 p.m. June 5, 2007 - MarketWatch
Tuesday's biggest stock gainers and decliners 4:43 p.m. April 17, 2007 - Michael Baron
Oncolytics shares rise on data from Reolysin study 9:37 a.m. April 17, 2007 - Gabriel Madway
Oncolytics Biotech up 13% at $2.20 9:04 a.m. April 17, 2007 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:09 p.m. Feb. 6, 2007 - Michael Baron
Wednesday's biggest U.S. stock gainers and decliners 5:55 p.m. Jan. 3, 2007 - MarketWatch
Oncolytics Biotech gets U.K. approval for Reolysin trial 10:45 a.m. Jan. 3, 2007 - Gabriel Madway
Oncolytics Biotech shares up 4.3% at $2.18 10:38 a.m. Jan. 3, 2007 - Gabriel Madway
Oncolytics Biotech gets U.K. approval for Reolysin trial 10:38 a.m. Jan. 3, 2007 - Gabriel Madway
Friday's biggest stock gainers and decliners 2:07 p.m. Dec. 22, 2006 - MarketWatch
Oncolytics starts patient enrollment in Reolysin trial 11:00 a.m. Dec. 22, 2006 - Gabriel Madway
Oncolytics starts patient enrollment in Reolysin trial 10:50 a.m. Dec. 22, 2006 - Gabriel Madway
Oncolytics down 8.8% at $4.57 9:48 a.m. Dec. 13, 2005 - Tomi Kilgore
Oncolytics to issue 3.2 million unit private offering 6:49 a.m. Dec. 13, 2005 - Simon Kennedy
On the Road to Riches in Biotech 4:10 a.m. Dec. 28, 2013 - Barrons.com
A confused Needham maintains Buy rating on Oncolytics 11:54 a.m. Nov. 25, 2013 - Seeking Alpha
Oncolytics: One Drug To Treat Them All, Or A Complete Dud, Data Is Not Bad 12:51 a.m. Nov. 24, 2013 - Seeking Alpha
After premarket head fake, Oncolytics Biotech slides as investors parse results 10:51 a.m. Nov. 21, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Oncolytics Biotech rallies on Reolysin results 8:32 a.m. Nov. 21, 2013 - Seeking Alpha
Oncolytics Biotech Announces Positive Top-Line Data from REO 018 Randomized Study of REOLYSIN 5:28 a.m. Nov. 21, 2013 - benzinga.com
Thursday’s Biggest Stock Losers: SGOC, VJET, and More 4:56 a.m. Nov. 21, 2013 - InvestorPlace.com
Oncolytics Announces Positive Phase 2 REOLYSIN Data 4:36 a.m. Oct. 28, 2013 - benzinga.com
Oncolytics Announces Progression Free Survival Data for Phase 2 REOLYSIN Study 4:43 a.m. Oct. 22, 2013 - benzinga.com
Encouraging Data on Oncolytics' Reolysin - Analyst Blog 4:40 p.m. Sept. 10, 2013 - Zacks.com
Five Highly Unusual Hot Stocks on the Move for Monday 10:34 a.m. Sept. 9, 2013 - 247WallSt.com
Oncolytics Drug Shrinks Tumors in 92% of Patients in Study 8:19 a.m. Sept. 9, 2013 - FOXBusiness
Oncolytics Biotech Announces Positive Final Tumour Response Data for US Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer 4:34 a.m. Sept. 9, 2013 - benzinga.com
Oncolytics Biotech: A Cancer Drug Pioneer Worth Looking Into 1:59 p.m. Aug. 9, 2013 - Seeking Alpha
Promising Data on ONCY's Reolysin - Analyst Blog 4:40 p.m. May 24, 2013 - Zacks.com
Oncolytics Announces First Stage of Metastatic Melanoma Phase 2 Trial Meets Primary Endpoint 4:41 a.m. May 22, 2013 - benzinga.com
Oncolytics Biotech's CEO Presents at 2013 Annual Meeting of Shareholders Conference (Transcript) 12:33 a.m. May 11, 2013 - Seeking Alpha
Oncolytics: A Failing Biopharma, Or An Opportune Buy? 2:15 a.m. April 8, 2013 - Seeking Alpha
Oncolytics Phase 2 Study of REOLYSIN Meets Primary Endpoint in Squamous Cell Lung Cancer 4:33 a.m. March 28, 2013 - benzinga.com
Oncolytics Biotech® Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference 6:30 a.m. Dec. 3, 2013 - PR Newswire
FDA Clearance, Management Changes, and Clinical Study Updates - Research Report on Illumina, Array, Oncolytics, Intrexon, and STERIS 8:00 a.m. Nov. 26, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of ONCOLYTICS BIOTECH INC. for Possible Violations of Federal Securities Laws 1:29 p.m. Nov. 22, 2013 - BusinessWire
HOLX, GMCR, ONCY and ZNGA added to NASDAQ Active Stock Watch List at EPR 10:13 a.m. Nov. 21, 2013 - ACCESSWIRE
Oncolytics Biotech® Inc. Announces Positive Top-Line Data from REO 018 Randomized Study of REOLYSIN® in Head and Neck Cancers 6:00 a.m. Nov. 21, 2013 - PR Newswire
Oncolytics Biotech® Inc. Announces Third Quarter 2013 Results 6:30 a.m. Nov. 7, 2013 - PR Newswire
Oncolytics Biotech® Inc. Collaborators Present Positive Data Correlating Specific Biomarkers with Survival in NSCLC Patients Treated with REOLYSIN®, Carboplatin and Paclitaxel 5:30 a.m. Oct. 28, 2013 - PR Newswire
Oncolytics Biotech® Inc. Announces Progression Free Survival Data for Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer 5:30 a.m. Oct. 22, 2013 - PR Newswire
Stockboard Custom Reports on Oncolytics Biotech Inc. and Valeant Pharmaceuticals International Inc. 8:04 a.m. Oct. 16, 2013 - ACCESSWIRE
Oncolytics Biotech Inc. Collaborators to Present Positive Clinical Trial Data at the 15th Annual World Conference on Lung Cancer 12:15 p.m. Oct. 1, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ONCY, RMTI, TEVA and VPHM 8:01 a.m. Sept. 16, 2013 - ACCESSWIRE
Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL 7:00 a.m. Sept. 12, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences 4:00 p.m. Sept. 9, 2013 - PR Newswire
Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer 5:30 a.m. Sept. 9, 2013 - PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at the 2013 Wedbush PacGrow Life Sciences Management Access Conference 4:00 p.m. Aug. 13, 2013 - PR Newswire
Lorus Therapeutics Appoints Dr. Brad Thompson, an Experienced Biotechnology Professional, to the Board of Directors 6:01 a.m. June 27, 2013 - Marketwire
Oncolytics Biotech? Inc. to Present at 2013 Jefferies Global Healthcare Conference 5:30 a.m. June 4, 2013 - PR Newswire
Oncolytics Biotech? Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial 5:30 a.m. May 22, 2013 - PR Newswire
Media Advisory - Oncolytics Biotech? Inc. to Present at Bank of America Merrill Lynch Health Care Conference 5:30 a.m. May 14, 2013 - PR Newswire
Oncolytics prices offering at 14% discount 2:21 p.m. Feb. 20, 2013 - MarketWatch.com
Canada hot stocks : Oncolytics, Just Energy 12:37 p.m. Feb. 8, 2013 - MarketWatch.com
Oncolytics shares up on positive Reolysin results 8:59 a.m. Feb. 8, 2013 - MarketWatch.com
Oncolytics rises 27% after positive Phase III data 8:45 a.m. Dec. 13, 2012 - Steve Gelsi
Oncolytics Biotech up 27% in premarket 8:38 a.m. Dec. 13, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 3:18 p.m. Sept. 12, 2012 - MarketWatch
Tuesday's biggest stock gainers and decliners 4:24 p.m. June 5, 2007 - MarketWatch
Tuesday's biggest stock gainers and decliners 4:43 p.m. April 17, 2007 - Michael Baron
Oncolytics shares rise on data from Reolysin study 9:37 a.m. April 17, 2007 - Gabriel Madway
Oncolytics Biotech up 13% at $2.20 9:04 a.m. April 17, 2007 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:09 p.m. Feb. 6, 2007 - Michael Baron
Wednesday's biggest U.S. stock gainers and decliners 5:55 p.m. Jan. 3, 2007 - MarketWatch
Oncolytics Biotech gets U.K. approval for Reolysin trial 10:45 a.m. Jan. 3, 2007 - Gabriel Madway
Oncolytics Biotech shares up 4.3% at $2.18 10:38 a.m. Jan. 3, 2007 - Gabriel Madway
Oncolytics Biotech gets U.K. approval for Reolysin trial 10:38 a.m. Jan. 3, 2007 - Gabriel Madway
Friday's biggest stock gainers and decliners 2:07 p.m. Dec. 22, 2006 - MarketWatch
Oncolytics starts patient enrollment in Reolysin trial 11:00 a.m. Dec. 22, 2006 - Gabriel Madway
Oncolytics starts patient enrollment in Reolysin trial 10:50 a.m. Dec. 22, 2006 - Gabriel Madway
Oncolytics down 8.8% at $4.57 9:48 a.m. Dec. 13, 2005 - Tomi Kilgore
Oncolytics to issue 3.2 million unit private offering 6:49 a.m. Dec. 13, 2005 - Simon Kennedy
On the Road to Riches in Biotech 4:10 a.m. Dec. 28, 2013 - Barrons.com
A confused Needham maintains Buy rating on Oncolytics 11:54 a.m. Nov. 25, 2013 - Seeking Alpha
Oncolytics: One Drug To Treat Them All, Or A Complete Dud, Data Is Not Bad 12:51 a.m. Nov. 24, 2013 - Seeking Alpha
After premarket head fake, Oncolytics Biotech slides as investors parse results 10:51 a.m. Nov. 21, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Oncolytics Biotech rallies on Reolysin results 8:32 a.m. Nov. 21, 2013 - Seeking Alpha
Oncolytics Biotech Announces Positive Top-Line Data from REO 018 Randomized Study of REOLYSIN 5:28 a.m. Nov. 21, 2013 - benzinga.com
Thursday’s Biggest Stock Losers: SGOC, VJET, and More 4:56 a.m. Nov. 21, 2013 - InvestorPlace.com
Oncolytics Announces Positive Phase 2 REOLYSIN Data 4:36 a.m. Oct. 28, 2013 - benzinga.com
Oncolytics Announces Progression Free Survival Data for Phase 2 REOLYSIN Study 4:43 a.m. Oct. 22, 2013 - benzinga.com
Encouraging Data on Oncolytics' Reolysin - Analyst Blog 4:40 p.m. Sept. 10, 2013 - Zacks.com
Five Highly Unusual Hot Stocks on the Move for Monday 10:34 a.m. Sept. 9, 2013 - 247WallSt.com
Oncolytics Drug Shrinks Tumors in 92% of Patients in Study 8:19 a.m. Sept. 9, 2013 - FOXBusiness
Oncolytics Biotech Announces Positive Final Tumour Response Data for US Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer 4:34 a.m. Sept. 9, 2013 - benzinga.com
Oncolytics Biotech: A Cancer Drug Pioneer Worth Looking Into 1:59 p.m. Aug. 9, 2013 - Seeking Alpha
Promising Data on ONCY's Reolysin - Analyst Blog 4:40 p.m. May 24, 2013 - Zacks.com
Oncolytics Announces First Stage of Metastatic Melanoma Phase 2 Trial Meets Primary Endpoint 4:41 a.m. May 22, 2013 - benzinga.com
Oncolytics Biotech's CEO Presents at 2013 Annual Meeting of Shareholders Conference (Transcript) 12:33 a.m. May 11, 2013 - Seeking Alpha
Oncolytics: A Failing Biopharma, Or An Opportune Buy? 2:15 a.m. April 8, 2013 - Seeking Alpha
Oncolytics Phase 2 Study of REOLYSIN Meets Primary Endpoint in Squamous Cell Lung Cancer 4:33 a.m. March 28, 2013 - benzinga.com
Oncolytics Biotech® Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference 6:30 a.m. Dec. 3, 2013 - PR Newswire
FDA Clearance, Management Changes, and Clinical Study Updates - Research Report on Illumina, Array, Oncolytics, Intrexon, and STERIS 8:00 a.m. Nov. 26, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of ONCOLYTICS BIOTECH INC. for Possible Violations of Federal Securities Laws 1:29 p.m. Nov. 22, 2013 - BusinessWire
HOLX, GMCR, ONCY and ZNGA added to NASDAQ Active Stock Watch List at EPR 10:13 a.m. Nov. 21, 2013 - ACCESSWIRE
Oncolytics Biotech® Inc. Announces Positive Top-Line Data from REO 018 Randomized Study of REOLYSIN® in Head and Neck Cancers 6:00 a.m. Nov. 21, 2013 - PR Newswire
Oncolytics Biotech® Inc. Announces Third Quarter 2013 Results 6:30 a.m. Nov. 7, 2013 - PR Newswire
Oncolytics Biotech® Inc. Collaborators Present Positive Data Correlating Specific Biomarkers with Survival in NSCLC Patients Treated with REOLYSIN®, Carboplatin and Paclitaxel 5:30 a.m. Oct. 28, 2013 - PR Newswire
Oncolytics Biotech® Inc. Announces Progression Free Survival Data for Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer 5:30 a.m. Oct. 22, 2013 - PR Newswire
Stockboard Custom Reports on Oncolytics Biotech Inc. and Valeant Pharmaceuticals International Inc. 8:04 a.m. Oct. 16, 2013 - ACCESSWIRE
Oncolytics Biotech Inc. Collaborators to Present Positive Clinical Trial Data at the 15th Annual World Conference on Lung Cancer 12:15 p.m. Oct. 1, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ONCY, RMTI, TEVA and VPHM 8:01 a.m. Sept. 16, 2013 - ACCESSWIRE
Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL 7:00 a.m. Sept. 12, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences 4:00 p.m. Sept. 9, 2013 - PR Newswire
Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer 5:30 a.m. Sept. 9, 2013 - PR Newswire
Media Advisory - Oncolytics Biotech® Inc. to Present at the 2013 Wedbush PacGrow Life Sciences Management Access Conference 4:00 p.m. Aug. 13, 2013 - PR Newswire
Lorus Therapeutics Appoints Dr. Brad Thompson, an Experienced Biotechnology Professional, to the Board of Directors 6:01 a.m. June 27, 2013 - Marketwire
Oncolytics Biotech? Inc. to Present at 2013 Jefferies Global Healthcare Conference 5:30 a.m. June 4, 2013 - PR Newswire
Oncolytics Biotech? Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial 5:30 a.m. May 22, 2013 - PR Newswire
Media Advisory - Oncolytics Biotech? Inc. to Present at Bank of America Merrill Lynch Health Care Conference 5:30 a.m. May 14, 2013 - PR Newswire
(0)
(0)